REQUEST A DEMO
Total
USD $0.00
Search more companies

Kraszna-Pharma Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: KRASZNA-PHARMA Gyogyszertar es Gyogyhatasu Keszitmenyek Kereskedelmi es Szolgaltato Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Kraszna-Pharma Bt. is based in Hungary, with the head office in Kocsord. The enterprise operates in the Pharmacies and Drug Stores industry. The enterprise was incorporated on August 16, 1993. It currently has a total number of 6 (2024) employees. From the latest financial highlights, Kraszna-Pharma Bt. reported a net sales revenue drop of 0.83% in 2023. During that time, Kraszna-Pharma Bt.’s total assets decreased by 11.99%. In 2023, Kraszna-Pharma Bt.’s net profit margin decreased by 1.05%.

Headquarters
Szent Istvan u. 47.
Kocsord; Szabolcs-Szatmar-Bereg; Postal Code: 4751

Contact Details: Purchase the Kraszna-Pharma Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Kraszna-Pharma Bt. report to view the information.
Outstanding Shares:
Purchase the Kraszna-Pharma Bt. report to view the information.
Registered Capital:
Purchase the Kraszna-Pharma Bt. report to view the information.
Incorporation Date:
August 16, 1993
Key Executives
Purchase this report to view the information.
Business Manager
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Kraszna-Pharma Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
-0.83%
Total operating revenue
-0.78%
Operating profit (EBIT)
-78.42%
EBITDA
-117.37%
Net Profit (Loss) for the Period
-50.5%
Total assets
-11.99%
Total equity
-26.56%
Operating Profit Margin (ROS)
-0.91%
Net Profit Margin
-1.05%
Return on Equity (ROE)
-18.52%
Quick Ratio
-0.47%
Cash Ratio
-0.2%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?